Published :
Tables : 44
Figures : 41
Category : Healthcare
No. of Pages : 213
Report Code : HC-U9959
Tinea Pedis Treatment Market Overview: The contagious fungal infection tinea pedis, also known as athlete's foot, affects the skin on the feet. It can also spread on the toenails or hands. Most often, this occurs when feet become extremely sweaty and tight-fitting shoes are worn. This fungal infection is often seen in athletes, hence the name athlete's foot. Although it is not serious, an athlete's foot can be difficult to treat. You should immediately contact your doctor if you suspect that you may have athlete's foot. Direct contact with infected people or contamination of surfaces can lead to the spread of the fungus. The fungus thrives when it is warm and moist. It is most common in swimming pools, locker rooms, and showers. In some cases, an athlete's foot can cause complications. Mild complications can include allergic reactions to the fungus that can cause blistering on the hands or feet. The fungal infection can also return even after treatment. If a secondary bacterial infection occurs, there may be worse complications. Your foot may become swollen and painful. Additional signs of bacterial infections include fever, drainage, and pus. The bacterial infection could also spread to your lymph system. An infection of the skin can lead to lymph nodes or infections in your lymphatic system. Athlete's foot is treated first with antifungals. Clotrimazole is the most commonly used antifungal drug. Home remedies can be used to treat athlete's foot. Athlete's foot can also be treated with over-the-counter remedies. With some success, tea tree oil has been used to treat athletes' foot. The research and development of antifungal medications will be major factors driving the market's growth over the forecast period. The market for tinea pedis treatments is also expected to grow due to a large number of immunocompromised patients. The market growth is also expected to be slowed by the increase in tinea podis. The timeline also shows that the lack of knowledge about tinea podis and the treatment options is expected to hinder the growth of the market for tineapedis treatments. The potential growth of the tinea-pedis market will also be facilitated by the increasing aging population. The strict approval process for new drugs or therapies could hinder the market's growth in the future. The rise in infectious diseases has been increasing worldwide over the past several decades due to changes in ecosystems and animal infection. This has resulted in the development of new fungal infections. Long-term antifungal drug prophylaxis for high-risk patients and long-term therapeutic use have helped to establish (multi-) drug resistance. FutureWise Market Research has instantiated a report that provides an intricate analysis of Tinea Pedis Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Tinea Pedis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Tinea Pedis Treatment Market: • Zimmer Biomet • Smith & nephew • Zjrkonzahn • Waldermar Link • Dragonbio • Stryker • Aesculap • United Orthopedic Corporation • GlaxoSmithKline PLC (Note: The list of the major players will be updated with the latest market scenario and trends) Tinea Pedis Treatment Market Segmentation: By Disease Type • Interdigital Tinea Pedis • Plantar Tinea Pedis • vesicular Tinea Pedis By Route of Administration • Oral • Topical o Gel o Creams o Spary o Lotions o Powders By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Tinea Pedis Treatment Market By Disease Type, By Route of Administration and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The contagious fungal infection tinea pedis, also known as athlete's foot, affects the skin on the feet. It can also spread on the toenails or hands. Most often, this occurs when feet become extremely sweaty and tight-fitting shoes are worn. This fungal infection is often seen in athletes, hence the name athlete's foot. Although it is not serious, an athlete's foot can be difficult to treat. You should immediately contact your doctor if you suspect that you may have athlete's foot. Direct contact with infected people or contamination of surfaces can lead to the spread of the fungus. The fungus thrives when it is warm and moist. It is most common in swimming pools, locker rooms, and showers. In some cases, an athlete's foot can cause complications. Mild complications can include allergic reactions to the fungus that can cause blistering on the hands or feet. The fungal infection can also return even after treatment. If a secondary bacterial infection occurs, there may be worse complications. Your foot may become swollen and painful. Additional signs of bacterial infections include fever, drainage, and pus. The bacterial infection could also spread to your lymph system. An infection of the skin can lead to lymph nodes or infections in your lymphatic system. Athlete's foot is treated first with antifungals. Clotrimazole is the most commonly used antifungal drug. Home remedies can be used to treat athlete's foot. Athlete's foot can also be treated with over-the-counter remedies. With some success, tea tree oil has been used to treat athletes' foot. The research and development of antifungal medications will be major factors driving the market's growth over the forecast period. The market for tinea pedis treatments is also expected to grow due to a large number of immunocompromised patients. The market growth is also expected to be slowed by the increase in tinea podis. The timeline also shows that the lack of knowledge about tinea podis and the treatment options is expected to hinder the growth of the market for tineapedis treatments. The potential growth of the tinea-pedis market will also be facilitated by the increasing aging population. The strict approval process for new drugs or therapies could hinder the market's growth in the future. The rise in infectious diseases has been increasing worldwide over the past several decades due to changes in ecosystems and animal infection. This has resulted in the development of new fungal infections. Long-term antifungal drug prophylaxis for high-risk patients and long-term therapeutic use have helped to establish (multi-) drug resistance. FutureWise Market Research has instantiated a report that provides an intricate analysis of Tinea Pedis Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Tinea Pedis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Tinea Pedis Treatment Market: • Zimmer Biomet • Smith & nephew • Zjrkonzahn • Waldermar Link • Dragonbio • Stryker • Aesculap • United Orthopedic Corporation • GlaxoSmithKline PLC (Note: The list of the major players will be updated with the latest market scenario and trends) Tinea Pedis Treatment Market Segmentation: By Disease Type • Interdigital Tinea Pedis • Plantar Tinea Pedis • vesicular Tinea Pedis By Route of Administration • Oral • Topical o Gel o Creams o Spary o Lotions o Powders By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Tinea Pedis Treatment Market By Disease Type, By Route of Administration and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Tinea Pedis Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Disease Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Tinea Pedis Treatment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Tinea Pedis Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Disease type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Disease type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Tinea Pedis Treatment Market, By Disease Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Interdigital Tinea Pedis 7.2. Plantar Tinea Pedis 7.3. vesicular Tinea Pedis 8. Tinea Pedis Treatment Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Oral 8.2. Topical 8.2.1. Gel 8.2.2. Creams 8.2.3. Spary 8.2.4. Lotions 8.2.5. Powders 9. North America Tinea Pedis Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Tinea Pedis Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Tinea Pedis Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Tinea Pedis Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Zimmer Biomet 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Smith & nephew 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Zjrkonzahn 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Waldermar Link 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Dragonbio 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Stryker 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Aesculap 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. United Orthopedic Corporation 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. GlaxoSmithKline PLC 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics